Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners is a venture capital firm based in Palo Alto, United States. This profile covers what Venrock Healthcare Capital Partners invests in, its typical stage and check size, and how founders can get in front of it in 2026.
Venrock Healthcare Capital Partners is a fund dedicated to investing in publicly-held and privately-held healthcare companies.
- Investment focus
- Healthcare & Biotech
- Location
- Palo Alto, United States
- Founded
- 1969
- Team size
- 11-50
- Investments
- 10
- Typical round
- $155M
How to pitch Venrock Healthcare Capital Partners
The founders who hear back from Venrock Healthcare Capital Partners lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with Venrock Healthcare Capital Partners
Frequently Asked Questions
What does Venrock Healthcare Capital Partners invest in?
Venrock Healthcare Capital Partners focuses on Healthcare & Biotech. Match your sector and stage before reaching out, then find similar active investors on Round Funded.
What is Venrock Healthcare Capital Partners's typical check size?
Venrock Healthcare Capital Partners's typical round is around $155M. Use it as a signal for whether your raise fits its stage.
Is Venrock Healthcare Capital Partners actively investing?
Yes, Venrock Healthcare Capital Partners is an active a venture capital firm. Reach out with a personalized pitch that fits its stage and focus, then track who opens it.
Where is Venrock Healthcare Capital Partners based?
Venrock Healthcare Capital Partners is based in Palo Alto, United States. You can reach out from anywhere with a pitch that matches its focus.
How do I contact Venrock Healthcare Capital Partners?
Unlock Venrock Healthcare Capital Partners's verified email and reach out with a personalized pitch on Round Funded Accelerator. We show only deliverable contacts, so your outreach does not bounce.